SCHEMBL4894435

SCHEMBL4894435

CCN(Sc1ccc(Oc2ccc(OC)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
KEAP1 Q14145 3/20 0.42
NFE2L2 Q16236 3/20 0.42
TAS2R14 Q9NYV8 3/20 0.41
PTGES O14684 1/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP2C9 P11712 1/20 0.38
APEX1 P27695 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PGR P06401 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898271 0.94 POLB (0.44) POLBPTGESLMNAHTTSMN1; SMN2
SCHEMBL4903896 0.94 LMNA (0.46) POLBPTGESLMNAHTTSMN1; SMN2
SCHEMBL4905724 0.93 POLB (0.43) POLBLMNAHTTSMN1; SMN2NPC1
SCHEMBL4906518 0.92 POLB (0.43) POLBLMNAHTTSMN1; SMN2NPC1
SCHEMBL4905969 0.92 POLB (0.43) POLBTAS2R14LMNAHTTSMN1; SMN2
SCHEMBL4905300 0.92 POLB (0.43) POLBTAS2R14PTGESLMNAHTT
SCHEMBL4904025 0.91 ALDH1A1 (0.45) POLBKEAP1NFE2L2PTGESLMNA
SCHEMBL4904701 0.90 POLB (0.41) POLBLMNAHTTSMN1; SMN2NPC1
SCHEMBL4906844 0.89 POLB (0.41) POLBLMNAMMP9MMP13MCL1
SCHEMBL4899894 0.89 LMNA (0.43) POLBLMNAHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885KEAP1 810/4885NFE2L2 446/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD POLB 1807/4885KEAP1 810/4885NFE2L2 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.